Workflow
CEI(688128)
icon
Search documents
甘李药业签订不低于30亿元甘精胰岛素相关供应框架协议丨公告精选
Group 1: Company Announcements - Ganli Pharmaceutical signed a technology transfer and supply agreement with FZ and BIOMM, with a total supply framework agreement amount expected to be no less than 3 billion RMB [1] - Upwind New Materials completed the transfer of 121 million shares, changing its controlling shareholder to Zhiyuan Hengyue, associated with Zhiyuan Robotics [2] - Poly Developments plans to publicly issue corporate bonds not exceeding 15 billion RMB for various purposes including debt repayment and project construction [3] Group 2: Shareholder Actions - Lenovo Holdings reduced its stake in Lakala by 8.0781 million shares, decreasing its ownership from 25.00% to 23.97% [4] - Fenghuo Communication plans to repurchase shares with a budget between 75 million and 150 million RMB, with a maximum repurchase price of 40.53 RMB per share [5] - Hualing Cable intends to acquire control of San Bamboo Intelligent for no more than 270 million RMB to enhance its capabilities in robotics and high-frequency transmission [6] Group 3: Market Developments - Guiguang Network clarified that rumors regarding major collaborations with Huawei Cloud and restructuring with state-owned enterprises are untrue [7] - Dongshan Precision is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international presence [8] - Wolong Nuclear Materials' subsidiary plans to invest up to 1 billion RMB in a new materials project in Suzhou [9] Group 4: Other Corporate Activities - Chao Xun Communication's management completed their share reduction plan, with specific shares sold by board members [10] - Various companies are involved in significant project bids and collaborations, including China Electric Research and others [15]
中国电研:股东询价转让定价情况提示性公告
Zheng Quan Ri Bao· 2025-09-23 11:24
Group 1 - The core point of the article is that China Electric Research announced the preliminary inquiry transfer price of 24.09 yuan per share based on the inquiry subscription situation as of September 23, 2025 [2]
9月23日重要公告一览
Xi Niu Cai Jing· 2025-09-23 10:18
Group 1 - Qianyu Medical's shareholder QM5 LIMITED plans to transfer approximately 6.6693 million shares, accounting for 2% of the company's total share capital [1] - Guizhou Platinum Industry intends to raise no more than 1.291 billion yuan for technological innovation platform construction, industrial transformation, and working capital [1] - Guangdong Construction has won a bid for the Guangzhou Financial City East District project with a contract value of 1.924 billion yuan [1] Group 2 - Sanfu New Science plans to repurchase shares with a total amount not less than 10 million yuan and not exceeding 15 million yuan [3] - Baiyun Mountain's subsidiary has entered the II phase of clinical trials for children's Xiao Chai Hu granules, aimed at treating pediatric gastrointestinal colds [4] - Lepu Medical has signed a strategic cooperation agreement with Hanhai Information for market promotion and operation rights in mainland China [5] Group 3 - Daotong Technology plans to transfer 46% of its stake in Saifang Technology for a total consideration of 109 million yuan [7] - Rizhao Port's shareholder Shandong Energy Group intends to reduce its stake by up to 3% [8] - Saiwei Electronics reports that the National Integrated Circuit Fund has reduced its stake by 6.3481 million shares, representing 0.87% of the total share capital [10] Group 4 - Changji Logistics proposes a cash dividend of 0.31 yuan per share for the 2025 interim period [11] - Xuelong Group's shareholder plans to reduce its stake by up to 1.95% [13] - Lianxiang Co. plans to reduce its stake by a total of 3.74% [15] Group 5 - Yingfeite's actual controller plans to reduce its stake by up to 2.82% [16] - Baolong Technology's director plans to reduce his stake by up to 0.11% [17] - China Electric Research's shareholder plans to transfer 2% of the company's shares through an inquiry transfer [18] Group 6 - Oriental Pearl plans to participate in establishing an investment fund with a total fundraising scale of 714 million yuan [19] - Tianqin Equipment's shareholder plans to reduce its stake by up to 1% [21] - Crystal Optoelectronics' shareholder plans to reduce its stake by up to 0.99% [22] Group 7 - Changchun Technology expects a net profit increase of 131.39% to 145.38% for the first three quarters of 2025 [22] - Jinhai Tong's shareholder plans to reduce its stake by up to 1% [24] - Zhongdian Electric's shareholder plans to reduce its stake by up to 3% [26] Group 8 - Zhixiang Jintai has signed exclusive cooperation agreements for two monoclonal antibody injections [27] - Chuangli Group's director plans to reduce his stake by up to 0.7% [28] - Henghui Security's shareholders plan to reduce their stake by a total of 2.34% [29] Group 9 - Tianci Materials' subsidiary has signed a supply cooperation agreement for no less than 800,000 tons of electrolyte products [29] - Tianci Materials has submitted an application for H-share listing on the Hong Kong Stock Exchange [30] - Zhongke Haixun has signed a strategic cooperation agreement with Beibu Gulf Port Group [30] Group 10 - China CNR has elected Sun Yongcai as the chairman of the board [31] - Baiwei Storage plans to issue H-shares and list on the Hong Kong Stock Exchange [32] - Shengxin Lithium Energy plans to acquire a 21% stake in Qicheng Mining for 1.456 billion yuan [33] Group 11 - Zhongjing Electronics plans to raise no more than 700 million yuan for various projects [35] - Dingxin Communications clarifies that its technology authorization from Pingtouge is unrelated to AI intelligent reasoning chips [37] - Rihai Intelligent's major shareholder plans to reduce its stake by up to 2.77% [38] Group 12 - Rihai Optical's actual controller plans to reduce his stake by up to 3% [39] - Xilong Science's actual controllers plan to reduce their stake by a total of 3% [40] - Honggong Technology plans to sign a project contract with a maximum investment of 450 million yuan [41] Group 13 - Mankang Pharmaceutical has signed a strategic cooperation agreement with Nanjing Haijing Pharmaceutical [42] - Mankang Pharmaceutical plans to raise no more than 1.033 billion yuan through a private placement [42] - Kaidi Co.'s shareholder plans to reduce its stake by up to 38,030 shares [43] Group 14 - Hesheng Co. has launched a stock option and restricted stock incentive plan totaling 3.6 million shares [44] - ST Yigou's shareholder plans to reduce its stake by up to 2.85% [46] - Jinziham's subsidiary plans to invest up to 300 million yuan in Zhongzheng Microelectronics [49]
中国电研(688128) - 中国电研股东询价转让定价情况提示性公告
2025-09-23 08:47
股东广州凯天投资管理中心(有限合伙)保证向中国电器科学研究院股份 有限公司(以下简称"本公司")提供的信息内容不存在任何虚假记载、误导性 陈述或者重大遗漏,并对其真实性、准确性和完整性依法承担法律责任。 本公司及全体董事保证本公告内容与信息披露义务人提供的信息一致。 重要内容提示: 证券代码:688128 证券简称:中国电研 公告编号:2025-034 中国电器科学研究院股份有限公司 股东询价转让定价情况提示性公告 特此公告。 中国电器科学研究院股份有限公司董事会 根据 2025 年 9 月 23 日询价申购情况,初步确定的本次询价转让价格为 24.09 元/股。 二、风险提示 (一)本次询价转让受让方及受让股数仅为初步结果,尚存在拟转让股份被 司法冻结、扣划等风险。询价转让的最终结果以中国证券登记结算有限责任公司 上海分公司最终办理结果为准。 1 (二)本次询价转让不涉及本公司控制权变更,不会影响本公司治理结构和 持续经营。 一、本次询价转让初步定价 (一)经向机构投资者询价后,初步确定的转让价格为 24.09 元/股。 (二)参与本次询价转让报价的机构投资者家数为 17 家,涵盖了基金管理 公司、证券公司 ...
中国电研:询价转让价格为24.09元/股
Mei Ri Jing Ji Xin Wen· 2025-09-23 08:43
每经AI快讯,9月23日,中国电研(688128.SH)公告称,根据2025年9月23日询价申购情况,初步确定的 本次询价转让价格为24.09元/股。本次询价转让拟转让股份已获全额认购,初步确定受让方为15家机构 投资者,拟受让股份总数为809万股。 ...
中国电研(688128.SH):初步确定询价转让价格为24.09元/股
智通财经网· 2025-09-23 08:31
智通财经APP讯,中国电研(688128.SH)披露股东询价转让定价情况,根据2025年9月23日询价申购情 况,初步确定的本次询价转让价格为24.09元/股。本次询价转让拟转让股份已获全额认购,初步确定受 让方为15家机构投资者,拟受让股份总数为809万股。 ...
中国电研:股东询价转让价格为24.09元/股
人民财讯9月23日电,中国电研(688128)9月23日公告,初步确定的股东询价转让价格为24.09元/股。此 次询价转让拟转让股份已获全额认购,初步确定受让方为15家机构投资者,拟受让股份总数为809万 股。 ...
中国电研:初步确定的本次询价转让价格为24.09元/股
Di Yi Cai Jing· 2025-09-23 08:25
中国电研晚间公告,根据2025年9月23日询价申购情况,初步确定的本次询价转让价格为24.09元/股。 参与本次询价转让报价的机构投资者家数为17家,涵盖了基金管理公司、证券公司、合格境外机构投资 者及私募基金管理人等专业机构投资者。参与本次询价转让报价的机构投资者合计有效认购股份数量为 964.5万股,对应的有效认购倍数为1.19倍。本次询价转让拟转让股份已获全额认购,初步确定受让方为 15家机构投资者,拟受让股份总数为809万股。 (文章来源:第一财经) ...
证券代码:688128 证券简称:中国电研 公告编号:2025-033
股东广州凯天投资管理中心(有限合伙)保证向本公司提供的信息内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其真实性、准确性和完整性依法承担法律责任。 本公司及全体董事保证本公告内容与信息披露义务人提供的信息一致。 重要内容提示: 登录新浪财经APP 搜索【信披】查看更多考评等级 炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! ● 拟参与中国电器科学研究院股份有限公司(以下简称"中国电研")首发前股东询价转让(以下简 称"本次询价转让")的股东为广州凯天投资管理中心(有限合伙)(以下简称"凯天投资"或"出让 方"); ● 出让方拟转让股份的总数为8,090,000股,占中国电研总股本的比例为2.00%; ● 本次询价转让不通过集中竞价交易方式或大宗交易方式进行,不属于通过二级市场减持。受让方通过 询价转让受让的股份,在受让后6个月内不得转让; ● 本次询价转让的受让方为具备相应定价能力和风险承受能力的机构投资者。 一、拟参与转让的股东情况 (一)出让方的名称、持股数量、持股比例 出让方委托中信建投证券股份有限公司(以下简称"中信建投证券")组织实施本次询价转让。截至2025 年9 ...
9月22日增减持汇总:中炬高新等3股增持 德明利等29股减持(表)
Xin Lang Zheng Quan· 2025-09-22 14:26
Summary of Key Points Core Viewpoint - On September 22, a total of 29 A-share listed companies disclosed share reduction plans, indicating a trend of insider selling in the market [1]. Group 1: Companies with Share Reduction Plans - Kaidi Co., Ltd. plans to reduce its shares by no more than 380,300 shares [3]. - Rihai Intelligent's largest shareholder intends to reduce its stake by no more than 2.77% [3]. - Xilong Science's controlling shareholders plan to collectively reduce their shares by no more than 3% [3]. - Aopu Optoelectronics' controlling shareholder has completed its reduction plan [3]. - Rijiu Optoelectronics' controlling shareholder, Chen Xiaoli, plans to reduce no more than 3% of the company's shares [3]. - Demingli's controlling shareholder has completed its reduction plan [3]. - Zhongshe Co., Ltd.'s shareholder Chen Fengjun intends to reduce no more than 1% of the company's shares [3]. - Henghui Security's shareholders plan to collectively reduce no more than 2.34% of the company's shares [3]. - Debang Technology's National Integrated Circuit Industry Investment Fund recently reduced its stake by 0.65% [3]. - Chuangli Group's director and deputy general manager, Geng Weidong, plans to reduce no more than 0.6956% of the company's shares [3]. - Zhongdian Electric's shareholder Wang Jiankai intends to reduce no more than 3% of the company's shares [3]. - SF Express' shareholder Liu Jilu plans to transfer no more than 7 million A-shares to his son-in-law [3]. - Tianqin Equipment's shareholder Zhang Peng plans to reduce no more than 1% of the company's shares [3]. - Shuijing Optoelectronics' shareholder Shen Gai Zhen intends to reduce no more than 0.99% of the company's shares [3]. - Yingfite's controlling shareholder plans to reduce no more than 2.82% of the company's shares [3]. - Baicheng Medical's part of the board and supervisors plan to reduce their shares [3]. - Guangting Information's SAIC Venture Capital plans to transfer 3.16% of the company's shares to SAIC Group [3]. - Sihui Fushi's controlling shareholder and its concerted parties recently reduced a total of 385,200 shares [3]. - Baolong Technology's director Wang Shengquan plans to reduce no more than 0.11% of the company's shares [3]. - Saiwei Electronics' National Integrated Circuit Industry Investment Fund recently reduced a total of 6.3481 million shares [3]. - Rizhao Port's Shandong Energy plans to reduce no more than 3% of the company's shares [3]. - Xuelong Group's shareholder Ningbo Lianzhan plans to reduce no more than 1.95% of the company's shares [3]. - China Electric Research's shareholder Kaitian Investment plans to transfer 8.09 million shares [3]. - Lianxiang Co., Ltd.'s shareholders plan to reduce no more than 2.58% and 1.16% of the company's shares [3]. - Yingnuo Laser's shareholder reduction plan has been completed [3]. - Zhejiang Pharmaceutical's shareholder Guotou Gaoke plans to reduce no more than 1% of the company's shares [3]. - Dingyang Technology's shareholders plan to transfer 3.184 million shares, accounting for 2% of the total share capital [3]. - Sanyou Medical's shareholder QM5 LIMITED plans to transfer 6.67 million shares, accounting for 2% of the total share capital [3].